16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reduced keratin expression in colorectal neoplasia and associated fields is reversible by diet and resection

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Patients with adenomatous colonic polyps are at increased risk of developing further polyps suggesting field-wide alterations in cancer predisposition. The current study aimed to identify molecular alterations in the normal mucosa in the proximity of adenomatous polyps and to assess the modulating effect of butyrate, a chemopreventive compound produced by fermentation of dietary residues.

          Methods

          A cross-sectional study was undertaken in patients with adenomatous polyps: biopsy samples were taken from the adenoma, and from macroscopically normal mucosa on the contralateral wall to the adenoma and from the mid-sigmoid colon. In normal subjects biopsies were taken from the mid-sigmoid colon. Biopsies were frozen for proteomic analysis or formalin-fixed for immunohistochemistry. Proteomic analysis was undertaken using iTRAQ workflows followed by bioinformatics analyses. A second dietary fibre intervention study arm used the same endpoints and sampling strategy at the beginning and end of a high-fibre intervention.

          Results

          Key findings were that keratins 8, 18 and 19 were reduced in expression level with progressive proximity to the lesion. Lesional tissue exhibited multiple K8 immunoreactive bands and overall reduced levels of keratin. Biopsies from normal subjects with low faecal butyrate also showed depressed keratin expression. Resection of the lesion and elevation of dietary fibre intake both appeared to restore keratin expression level.

          Conclusion

          Changes in keratin expression associate with progression towards neoplasia, but remain modifiable risk factors. Dietary strategies may improve secondary chemoprevention.

          Trial registration number

          ISRCTN90852168.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation.

          Widespread changes in gene expression drive tumorigenesis, yet our knowledge of how aberrant epigenomic and transcriptome profiles arise in cancer cells is poorly understood. Here, we demonstrate that metabolic transformation plays an important role. Butyrate is the primary energy source of normal colonocytes and is metabolized to acetyl-CoA, which was shown to be important not only for energetics but also for HAT activity. Due to the Warburg effect, cancerous colonocytes rely on glucose as their primary energy source, so butyrate accumulated and functioned as an HDAC inhibitor. Although both mechanisms increased histone acetylation, different target genes were upregulated. Consequently, butyrate stimulated the proliferation of normal colonocytes and cancerous colonocytes when the Warburg effect was prevented from occurring, whereas it inhibited the proliferation of cancerous colonocytes undergoing the Warburg effect. These findings link a common metabolite to epigenetic mechanisms that are differentially utilized by normal and cancerous cells because of their inherent metabolic differences. Copyright © 2012 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Acetylation: a regulatory modification to rival phosphorylation?

            The fact that histones are modified by acetylation has been known for almost 30 years. The recent identification of enzymes that regulate histone acetylation has revealed a broader use of this modification than was suspected previously. Acetylases are now known to modify a variety of proteins, including transcription factors, nuclear import factors and alpha-tubulin. Acetylation regulates many diverse functions, including DNA recognition, protein-protein interaction and protein stability. There is even a conserved structure, the bromodomain, that recognizes acetylated residues and may serve as a signalling domain. If you think all this sounds familiar, it should be. These are features characteristic of kinases. So, is acetylation a modification analogous to phosphorylation? This review sets out what we know about the broader substrate specificity and regulation of acetyl- ases and goes on to compare acetylation with the process of phosphorylation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Sodium butyrate inhibits histone deacetylation in cultured cells.

              Sodium butyrate in millimolar concentrations causes an accumulation of acetylated histone species in a variety of vertebrate cell lines. In all lines tested, butyrate caused hyperacetylation of H3 and H4, and in rat IRC8 cells, H2A and H2B were also affected. In Friend erythroleukemic cells, butyrate also induces the synthesis of a nonhistone chromosomal protein, IP25. butyrate does not affect the rate of histone acetylation in cell-free extracts of nuclei of Friend cells. Rather, this fatty acid inhibits histone deacetylation. Cell-free extracts of either control cells or butyrate-grown cells contain comparable levels of histone-deacetylating activity. This in vitro activity is inhibited by the addition of butyrate to the extracts. Thus butyrate appears to be an inhibitor of histone deacetylases both in vivo and in vitro.
                Bookmark

                Author and article information

                Journal
                BMJ Open Gastroenterol
                BMJ Open Gastroenterol
                bmjgastro
                bmjgastro
                BMJ Open Gastroenterology
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2054-4774
                2015
                17 April 2015
                : 2
                : 1
                : e000022
                Affiliations
                [1 ]Department of Chemical and Biological Engineering, ChELSI Institute, University of Sheffield , Sheffield, UK
                [2 ]Molecular Gastroenterology Research Group, Department of Oncology, University of Sheffield, The Medical School , Sheffield, UK
                [3 ]Department of Biological Sciences, The University of Hull , Hull, UK
                [4 ]Conservatoire National des Arts et Mmétiers , Paris, France
                [5 ]Department of Geography, University of Sheffield , Sheffield, UK
                [6 ]Human Nutrition Unit, Department of Oncology, University of Sheffield, The Medical School , Sheffield, UK
                [7 ]Department of Gastroenterology, Northern General Hospital , Sheffield, UK
                [8 ]Department of Pathology, Royal Hallamshire Hospital , Sheffield, UK
                [9 ]Insigneo Institute for in Silico Medicine, The University of Sheffield , Sheffield, UK
                Author notes
                [Correspondence to ] Dr Bernard Corfe; b.m.corfe@ 123456shef.ac.uk
                Article
                bmjgast-2014-000022
                10.1136/bmjgast-2014-000022
                4599164
                f024e8b4-f700-491c-853c-c5338f2107c9
                Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

                This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

                History
                : 28 October 2014
                : 19 December 2014
                : 22 December 2014
                Categories
                1506
                Colorectal Neoplasia

                adenoma,butyrate,cytokeratins,dietary fibre
                adenoma, butyrate, cytokeratins, dietary fibre

                Comments

                Comment on this article